Absolutely. I do think that when it comes to critical medications, we're seeing exactly what happens. We're seeing people going to emergency departments to get their hands on pediatric formulations of Tylenol. We saw shortages of key anaesthetics that I use in emergency care and the ICU.
Some kind of redundant capacity, some ability to make critical medications, really is an issue of security. In the U.S. they actually see it as a matter of national security. Hence, there was an executive order passed during COVID-19 that very clearly defined what those critical medications and other inputs in hospital were and how they could actually use the Defense Manufacturing Act to make them in the United States.
That's how they've dealt with it. They do have shortages, but it's just been managed much better, in that sense.